Comparison of knowledge of HIV status and treatment coverage between non-citizens and citizens: Botswana Combination Prevention Project (BCPP).


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 28 03 2019
accepted: 10 08 2019
entrez: 30 8 2019
pubmed: 30 8 2019
medline: 10 3 2020
Statut: epublish

Résumé

Non-citizens often face barriers to HIV care and treatment. Quantifying knowledge of positive HIV status and antiretroviral therapy (ART) coverage among non-citizens in a high HIV-prevalence country like Botswana that is close to achieving UNAIDS "90-90-90" targets may expose important gaps in achieving universal HIV testing and treatment. The Botswana Combination Prevention Project (BCPP) is a pair-matched cluster-randomized trial evaluating the impact of prevention interventions on HIV incidence in 30 rural or peri-urban communities. Community case finding and HIV testing were conducted in home and mobile venues in 15 intervention communities from October 2013-September 2017. In this secondary analysis, we compared HIV positivity, knowledge of positive HIV-status, and ART status among all citizens and non-citizens assessed at intake in the intervention communities. HIV status was assessed in 57,556 residents in the intervention communities; 4% (n = 2,463) were non-citizens. Five communities accounted for 81% of the total non-citizens assessed. A lower proportion of non-citizens were HIV-positive (15%; n = 369) compared to citizens (21%; n = 11,416) [p = 0.026]; however, a larger proportion of non-citizens did not know their HIV-positive status prior to BCPP testing (75%) as compared to citizens (15%) [p = 0.003]. Among residents with knowledge of their HIV-positive status before BCPP, 79% of the non-citizens (72/91) were on ART compared to 86% (8,267/9,652) of citizens (p = 0.137). Although non-citizens were less likely to know their HIV-positive status compared to citizens, there were no differences in treatment uptake among non-citizens and citizens who knew their status. Designing interventions for non-citizens that provide HIV testing and treatment services commensurate to that of citizens as well as targeting communities with the largest number of non-citizens may help close a meaningful gap in the HIV care cascade and ensure ethical treatment for all HIV-positive persons. ClinicalTrials.gov: NCT01965470 (Botswana Combination Prevention Project).

Identifiants

pubmed: 31465494
doi: 10.1371/journal.pone.0221629
pii: PONE-D-19-08918
pmc: PMC6715216
doi:

Banques de données

ClinicalTrials.gov
['NCT01965470']

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0221629

Subventions

Organisme : CGH CDC HHS
ID : U01 GH000447
Pays : United States
Organisme : CGH CDC HHS
ID : U2G GH000073
Pays : United States
Organisme : CGH CDC HHS
ID : U2G GH000419
Pays : United States
Organisme : CGH CDC HHS
ID : U2G GH001911
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Infect Dis. 2012 Aug 15;206(4):543-51
pubmed: 22711905
Curr Opin HIV AIDS. 2015 Nov;10(6):430-8
pubmed: 26352396
Lancet HIV. 2016 May;3(5):e221-30
pubmed: 27126489
J Int AIDS Soc. 2018 Jul;21 Suppl 4:e25137
pubmed: 30027621
PLoS One. 2018 Oct 24;13(10):e0204840
pubmed: 30356287

Auteurs

Tafireyi Marukutira (T)

Centers for Disease Control and Prevention, Gaborone, Botswana.
Public Health, Burnet Institute, Melbourne, Australia.
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Lisa Block (L)

Northrop Grumman Corporation, Atlanta, Georgia, United States of America.

Mary Grace Alwano (MG)

Centers for Disease Control and Prevention, Gaborone, Botswana.

Stephanie Behel (S)

Division of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Joseph N Jarvis (JN)

Centers for Disease Control and Prevention, Gaborone, Botswana.
Botswana-UPenn Partnership, Gaborone, Botswana.
Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Unoda Chakalisa (U)

Botswana-Harvard Partnership, Gaborone, Botswana.

Kate Powis (K)

Botswana-Harvard Partnership, Gaborone, Botswana.
Harvard T.H Chan School of Public Health, Boston, Massachusetts, United States of America.

Vladimir Novitsky (V)

Harvard T.H Chan School of Public Health, Boston, Massachusetts, United States of America.

William Bapati (W)

Tebelopele HIV Testing and Counselling Centre, Gaborone, Botswana.

Huisheng Wang (H)

Northrop Grumman Corporation, Atlanta, Georgia, United States of America.

Faith Ussery (F)

Division of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Refeletswe Lebelonyane (R)

Department of HIV/AIDS Prevention and Care, Botswana Ministry of Health, Gaborone, Botswana.

Lisa A Mills (LA)

Centers for Disease Control and Prevention, Gaborone, Botswana.

Janet Moore (J)

Division of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Pamela Bachanas (P)

Division of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH